TITLE

Caspofungin: A Viewpoint by Ben E. De Pauw

AUTHOR(S)
de Pauw, B.E.
PUB. DATE
June 2001
SOURCE
Drugs;Jun2001, Vol. 61 Issue 8, p1130
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Evaluates the efficacy of caspofungin in the treatment of fungal infections. Information on amphotericin B and azoles drugs for fungal infections; Drugs that can be combined with caspofungin.
ACCESSION #
4745472

 

Related Articles

  • Introduction to Antifungal Drugs. Dismukes, William E. // Clinical Infectious Diseases;4/1/2000, Vol. 30 Issue 4, p653 

    Presents an overview of available antifungal drugs in the United States. Side effects of polyene drugs; Advantages of the lipid formulations of amphotericin B; Limitations of the azoles drugs.

  • VAISTAI NUO MIKROSKOPINI#x0172; GRYB#x0172;. II DALIS. VAISTIN#x0116;S MED#x017D;IAGOS IR PREPARATAI NUO GRYB#x0172;. LITERAT#x016A;ROS AP#x017D;VALGA. Matusevičius, Algimantas; Ivaškienė, Marija; špakauskas, Vytautas // Veterinarija ir Zootechnika;2008, Vol. 44 Issue 66, p3 

    The incidence of fungal infections have tendency to increase worldwide. The need for new antifungal agents has arisen largely through the increase in numbers of fungal infections. Relatively few agents were available for treatment of mycoses, e.g. amphotericin B, flucytosine, griseofulvine and...

  • Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective. Kleinberg, M. // Medical Mycology;Feb2005 Supplement 1, Vol. 43, p289 

    Aspergillosis is a potentially lethal infection of immunocompromised patients. Until 10 years ago, antifungal therapy was largely limited to amphotericin B deoxycholate. Perceived poor response rates and inherent toxicities with amphotericin B deoxycholate were a major stimulus for the...

  • Application of caspofungin in China compared with amphotericin B and fluconazole. Chunyu Zhang; Jiaoying Cheng; Yan Jiang; Junyang Liu // Therapeutics & Clinical Risk Management;2014, Vol. 10, p737 

    Fungal infection has increased in the past 2 decades in China. There are three classes of antifungal drugs, polyenes, azoles, and echinocandins, that are applied frequently in China. Caspofungin, which disrupts the fungal cell wall glucan formation through inhibiting the enzyme 1,3-β-glucan...

  • Amphotericin B Is Cytotoxic at Locally Delivered Concentrations. Harmsen, Samuel; McLaren, Alex; Pauken, Christine; McLemore, Ryan // Clinical Orthopaedics & Related Research;Nov2011, Vol. 469 Issue 11, p3016 

    Background: Orthopaedic fungal infections are commonly treated with systemic amphotericin, which has a narrow therapeutic index and is associated with systemic toxicities. Local delivery of amphotericin has been described yet is poorly understood. As with bacterial infections, fungal infections...

  • Fungal Infections of the CNS: Treatment Strategies for the Immunocompromised Patient. Black, Katharine E.; Baden, Lindsey R. // CNS Drugs;2007, Vol. 21 Issue 4, p293 

    Infections with fungi cause significant morbidity in the immunocompromised host and invasion of the CNS may lead to devastating consequences. Vulnerable individuals include those with haematological malignancies, transplant recipients, and those infected with HIV. Potential pathogens include...

  • Mycophenolate mofetil/prednisolone/sirolimus.  // Reactions Weekly;8/18/2007, Issue 1165, p14 

    The article describes the case of a 45-year-old man who developed zygomycosis during immunosuppressive therapy with mycophenolate mofetil, prednisolone and sirolimus. The man, who has a history of renal transplantation, received IV liposomal amphotericin B, followed by voriconazole....

  • Caspofungin: A Review of its Use in the Treatment of Fungal Infections. McCormack, Paul L.; Perry, Caroline M. // Drugs;2005, Vol. 65 Issue 14, p2049 

    Caspofungin (Cancidas®) is the first of a new class of antifungal agents, the echinocandins, that inhibit the synthesis of the fungal cell wall component β-(1,3)-D-glucan. Caspofungin is administered once daily by slow intravenous infusion and is used to treat infections caused by Candida...

  • histoplasmosis.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1083 

    An encyclopedia entry for "histoplasmosis," is presented. It refers to a systemic fungal respiratory disease caused by Histoplasma capsulatum. The signs and symptoms differ from those of a mild self-limited infection. The disease is treated using high dose or long-term intravenous amphotericin B...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics